Prof Dr Gulali Aktas, Abant Izzet Baysal University Hospital, Turkey
Prof. Dr. Gulali Aktas is a dedicated physician with 24 years of experience in internal medicine. As an academician for 13 years, he has mentored countless medical students and contributed to significant research. He holds an MD and Associate Professorship from Abant Izzet Baysal University. His prolific work includes 183 international journal publications, 19 conference presentations, and 11 book chapters. Recognized for his excellence, he was nominated for the Raise the Line Faculty Award in 2022 and is listed in Stanford University’s top 2% scientists. Fluent in Turkish, English, and basic German, he champions patient-centered care and lifelong learning. 🏥📚🌟
Publication profile
google scholar
Education
Dr. Gulali Aktas is an Associate Professor of Internal Medicine since 2015. They completed their Internal Medicine residency (PhD equivalent) at Ondokuz Mayis University, Samsun, Turkey (2003-2008), and Pulmonology residency at Yedikule Training and Research Hospital, Istanbul, Turkey (2002-2003). They earned their MD from Ondokuz Mayis University in 2000. With 211 research contributions published in peer-reviewed journals and an impressive H-index of 35 (WoS), 42 (Google Scholar), and 36 (Scopus), Dr. Gulali Aktas is a prominent researcher. Fluent in Turkish, English, and basic German, they are known for their honesty, hard work, optimism, and foresight. 🌟📚🩺🌍
Experience
From 2011 to 2014, courses such as Dyspnea and Edema, Approach to Chest Pain, Fever and Hyperthermia, and Leukopenia and Leukocytosis were taught in the spring, while Chronic Leukemia, Aplastic Anemia and Myelodysplasia, and Principles of Blood Transfusion were covered in the autumn. Rheumatology topics like Anamnesis, Physical Examination, and Laboratory Test Analysis were emphasized. Other subjects included Familial Mediterranean Fever, Behcet’s Disease, Chronic Pancreatitis, Liver Cirrhosis, Esophageal Diseases, Colon Polyps, Celiac Disease, Chronic Viral and Non-Viral Hepatitis, and Mesenteric Ischemia. 🩺📚✨
Presentations
Dr. Gulali Aktaş has presented several notable studies. At the 30th World Congress of Endourology in 2012, his team discussed “Warfarin intoxication induced bilateral renal hematoma” (📚🩸). He compared surgical techniques for pylonidal sinus surgery and explored sleep quality in IBS patients at the XVI Annual European Society of Surgery (🔪💤). In 2013, at the 50th ERA-EDTA Congress, he highlighted the effects of nocturnal blood pressure on hemodialysis patients’ nutrition (🌙🩺). His research on metabolic syndrome, presented at the 10th Metabolic Syndrome Symposium, investigated platelet volume, epicardial adipose tissue, and non-alcoholic hepatosteatosis (🩸📈). At the 51st ERA-EDTA Congress, he examined atrial conduction in hemodialysis patients (❤️🩺).
Research focus
G Aktas focuses on the use of hematological and biochemical markers as diagnostic and prognostic tools in various medical conditions. His research includes studies on the neutrophil-to-lymphocyte ratio as an indicator for diabetic control in type 2 diabetes mellitus and Hashimoto’s thyroiditis. He also explores the predictive value of the uric acid to HDL cholesterol ratio for metabolic syndrome and diabetes control, as well as novel inflammatory markers derived from hemogram parameters in irritable bowel syndrome and COVID-19. His work aims to improve diagnostic accuracy and patient outcomes. 🩸🔬📊
Publication top notes
Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus
Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto’s thyroiditis
Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus
Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?
Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus
Diabetes control could through platelet-to-lymphocyte ratio in hemograms
Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters
Could red cell distribution width be a marker in Hashimoto’s thyroiditis?
Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men
Hematological predictors of novel Coronavirus infection